- Home
- DNLI vs CPK Comparison
DNLI vs CPK Comparison
Compare DNLI & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | CPK |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DNLI | CPK |
|---|---|---|
| Price | $24.92 | $134.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | $34.33 | ★ $142.00 |
| AVG Volume (30 Days) | ★ 1.3M | 158.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 13.50 |
| EPS | N/A | ★ 3.51 |
| Revenue | N/A | ★ $930,000,000.00 |
| Revenue This Year | N/A | $8.39 |
| Revenue Next Year | $408.85 | $5.36 |
| P/E Ratio | ★ N/A | $39.20 |
| Revenue Growth | N/A | ★ 18.14 |
| 52 Week Low | $12.58 | $118.88 |
| 52 Week High | $27.30 | $140.83 |
Technical Indicators
Market Signals| Indicator | DNLI | CPK |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 51.89 |
| Support Level | $22.32 | $130.58 |
| Resistance Level | $25.74 | $139.05 |
| Average True Range (ATR) | 0.83 | 2.66 |
| MACD | 0.03 | -0.14 |
| Stochastic Oscillator | 62.75 | 52.50 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About CPK Chesapeake Utilities Corporation
Chesapeake Utilities Corp is an energy delivery company engaged in the distribution of natural gas, electricity, and propane; the transmission of natural gas; the generation of electricity and steam; and providing mobile compressed natural gas and other energy-related services to its customers. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland, and Florida are subject to regulation by PSC. Eastern Shore's natural gas transmission is subject to regulation by the FERC, and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.